arginine has been researched along with Blood Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (64.71) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rasheed, N; Attia, H; Fadda, L; Maysarah, N | 1 |
| Chakrabandhu, S; Chitapanarux, I; Chitapanarux, T; Chottaweesak, P; Jiratrachu, R; Pisprasert, V; Rasio, W; Sripan, P; Traisathit, P | 1 |
| Gladwin, MT; Kato, GJ; Morris, CR | 1 |
| Agata, N; Ebihara, T; Kawai, T; Lin, CY; Mukherjee, PM; Olsen, BR; Onji, M; Reichenberger, E; Saheki, Y; Senoo, M; Ueki, Y | 1 |
| Garnacho de Vega, A; Rey, C; Romero González, R | 1 |
| Alloisio, N; Delaunay, J; Forissier, A; Iolascon, A; Lorenzo, F; Miraglia del Giudice, E; Morle, L; Perrotta, S; Sciarratta, G | 1 |
| Etoh, T; Higuchi, M; Ikezawa, K; Kakishita, E; Kanamaru, A; Kunitomi, O; Nagai, K; Nakajima, T; Nishida, Y | 1 |
| Reinelt, D; Schmidt, P; Weinhold, D | 1 |
| Abe, K; Kumagai, N; Mouri, T; Seki, T; Yoshinaga, K | 1 |
| Burghouts, J; Clerico, M; Dautzenberg, B; Festen, J; Giaccone, G; Kho, GS; Kirkpatrick, A; Sahmoud, T; Sörenson, S; Splinter, TA; van Zandwijk, N | 1 |
| Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH | 1 |
| Martín-Aragonés, G; Martínez, JA; Marty, ML; Rafecas, FJ; Sanz, GF; Sanz, MA | 1 |
| Bundy, BN; DiSaia, PJ; Muss, H; Twiggs, LB | 1 |
| Kooiman, A; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Oosterom, AT; van Putten, WL; Vermorken, JB; Vriesendorp, R | 1 |
| de Vries, EG; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R; Willemse, PH | 1 |
| Bayle, C; Beaujean, F; Benhamou, E; Hartmann, O; Kalifa, C; Lemerle, J | 1 |
1 review(s) available for arginine and Blood Diseases
| Article | Year |
|---|---|
Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.
Topics: Arginase; Arginine; Free Radical Scavengers; Hematologic Diseases; Humans; Hypertension, Pulmonary; Nitric Oxide | 2008 |
4 trial(s) available for arginine and Blood Diseases
| Article | Year |
|---|---|
Arginine, glutamine, and fish oil supplementation in cancer patients treated with concurrent chemoradiotherapy: A randomized control study.
Topics: Arginine; Chemoradiotherapy; Dietary Supplements; Female; Fish Oils; Glutamine; Hematologic Diseases; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Patient Compliance; Severity of Illness Index; Treatment Outcome | 2020 |
Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hematologic Diseases; Humans; Kidney Diseases; Lymphoma; Podophyllotoxin; Prednisolone; Teniposide; Vincristine | 1982 |
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Diarrhea; Disease-Free Survival; Factor Analysis, Statistical; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Proportional Hazards Models; Survival Rate; Teniposide; Topoisomerase II Inhibitors | 1996 |
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1986 |
12 other study(ies) available for arginine and Blood Diseases
| Article | Year |
|---|---|
Carnosine and L-arginine attenuate the downregulation of brain monoamines and gamma aminobutyric acid; reverse apoptosis and upregulate the expression of angiogenic factors in a model of hemic hypoxia in rats.
Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Arginine; Biogenic Monoamines; Brain; Carnosine; Down-Regulation; Drug Therapy, Combination; gamma-Aminobutyric Acid; Gene Expression; Hematologic Diseases; Hypoxia; Inflammation Mediators; Male; Random Allocation; Rats; Rats, Wistar; Up-Regulation | 2020 |
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arginine; Bone Marrow Cells; Bone Resorption; CD11b Antigen; Cell Differentiation; Cherubism; Disease Models, Animal; Hematologic Diseases; Homozygote; Inflammation; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Macrophage Colony-Stimulating Factor; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Myeloid Cells; Osteoclasts; Phosphorylation; Proline; Protein-Tyrosine Kinases; RANK Ligand; Spleen; Syk Kinase; Tumor Necrosis Factor-alpha | 2007 |
[Potassium metabolism disorders (II)].
Topics: Addison Disease; Aldosterone; Arginine; Biological Transport; Diuretics; Hematologic Diseases; Humans; Hyperkalemia; Kidney Diseases; Mineralocorticoids; Paralyses, Familial Periodic; Potassium; Succinylcholine | 1981 |
Severe poikilocytosis associated with a de novo alpha 28 Arg-->Cys mutation in spectrin.
Topics: Arginine; Child, Preschool; Cysteine; Erythrocytes, Abnormal; Genotype; Hematologic Diseases; Humans; Male; Mutation; Polymorphism, Genetic; Spectrin | 1993 |
[Effect of MD-805, a synthetic thrombin inhibitor, on disseminated intravascular coagulation developing in hematological disorders].
Topics: Adult; Aged; Arginine; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hematologic Diseases; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombin | 1985 |
[Nosology and therapy of hyperammonemia in liver diseases].
Topics: Aged; Ammonia; Arginine; Electroencephalography; Female; Glutamates; Hematologic Diseases; Humans; Liver Cirrhosis; Male; Middle Aged; Neurologic Manifestations | 1969 |
TAMe esterase activity in human plasma under normal and pathological conditions.
Topics: Arginine; Cardiovascular Diseases; Colorimetry; Diabetes Mellitus; Disease; Esterases; Glomerulonephritis; Hematologic Diseases; Humans; Hyperthyroidism; Leukemia; Neoplasms; Nephrotic Syndrome; Pancreatic Diseases; Skin Diseases; Stomach Neoplasms | 1968 |
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma; Hematologic Diseases; Humans; Intracranial Pressure; Lomustine; Male; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide; Vomiting | 1976 |
Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Hematologic Diseases; Humans; Leukemia, Lymphoid; Male; Nervous System Neoplasms; Teniposide | 1986 |
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Hematologic Diseases; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1987 |
High-dose teniposide for refractory malignancies: a phase I study.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Podophyllotoxin; Skin Diseases; Teniposide | 1986 |
Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Humans; Infant; Male; Melphalan; Neuroblastoma; Teniposide | 1985 |